Paragon Care Limited
PGC.ASXHealth Care
Paragon Care provides end to end healthcare solutions including equipment and service solutions for acute, aged and primary care.
Market Data
$0.165
+0.1%$248.3M
-100000.0x
$-0.008
0.00%
-0.4%
Latest Earnings
Infinity Group Recovery and Earnings Update
1 June 2026
ParagonCare provides a recovery update on its Infinity Group exposure, with administrators indicating a preliminary distribution of A$11.7m-$15.8m (24%-32.5% recovery) from the administration process, plus A$3.4m already received from ATO. FY26 revenue is forecasted at A$3.7b with underlying EBITDA of A$95m-$100m, as the company navigates logistics cost pressures and pricing challenges. Key points: Infinity Group recovery: preliminary distribution estimated at A$11.7m-$15.8m (24%-32.5% recovery) from administration process; Additional A$3.4m cash recovery already received from ATO relating to GST previously paid on Infinity Group receivable; Potential for further recoveries through enforcement of guarantees from Infinity Group owners and directors
Recent Announcements
Infinity Group Recovery and Earnings Update
ParagonCare provides a recovery update on its Infinity Group exposure, with administrators indicating a preliminary distribution of A$11.7m-$15.8m (24%-32.5% recovery) from the administration process, plus A$3.4m already received from ATO. FY26 revenue is forecasted at A$3.7b with underlying EBITDA of A$95m-$100m, as the company navigates logistics cost pressures and pricing challenges. Key points: Infinity Group recovery: preliminary distribution estimated at A$11.7m-$15.8m (24%-32.5% recovery) from administration process; Additional A$3.4m cash recovery already received from ATO relating to GST previously paid on Infinity Group receivable; Potential for further recoveries through enforcement of guarantees from Infinity Group owners and directors
1H26 Appendix 4D and Half Year Report
ParagonCare reported a 3% increase in revenue to $1.9B for H1 FY26, but recorded a net loss of $21.3M primarily due to a $47.3M provision for bad debts from Infinity Retail Pharmacy Group's administration. Underlying EBITDA grew 3% to $49.0M, excluding one-off items, and the company continued its acquisition strategy with Somnotec Group and AHP purchases. Key points: Revenue increased 3% to $1.9B with gross margin up 6% to $173.9M; Underlying EBITDA grew 3.1% to $49.0M excluding one-off items; Continued expansion strategy with acquisitions of Somnotec Group and AHP Dental completing in December 2025 and July 2025 respectively
Get real-time alerts for PGC
Receive AI-powered earnings summaries and instant notifications when Paragon Care Limited releases results.
Register Free